NDC 0003-6120 – Opdivo Qvantig
Nivolumab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL · Injection, Solution · Subcutaneous
Product NDC0003-6120
Product details
- Brand name
- Opdivo Qvantig
- Generic name
- Nivolumab and hyaluronidase-nvhy
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761381
- Marketed since
- January 2, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Endoglycosidase; Programmed Death Receptor-1 Blocking Antibody
Active ingredients
- Nivolumab 120 mg/mL
- Hyaluronidase (human Recombinant) 2000 U/mL
Uses, dosage, side effects and warnings for Opdivo Qvantig →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0003-6120-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-6120-01) / 5 mL in 1 VIAL, SINGLE-DOSE | Jan 2, 2025 |
Other Opdivo Qvantig products
- 0003-3120 Nivolumab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL · Injection, Solution · E.R. Squibb & Sons, L.L.C.